To study the role of CD8 ␤ in T cell function, we derived a CD8 ␣ / ␤ Ϫ (CD8 Ϫ / Ϫ ) T cell hybridoma of the H-2K d -restricted N9 cytotoxic T lymphocyte clone specific for a photoreactive derivative of the Plasmodium berghei circumsporozoite peptide PbCS 252-260. This hybridoma was transfected either with CD8 ␣ alone or together with CD8 ␤ . All three hybridomas released interleukin 2 upon incubation with L cells expressing K d -peptide derivative complexes, though CD8 ␣ / ␤ cells did so more efficiently than CD8 ␣ / ␣ and especially CD8 Ϫ / Ϫ cells. More strikingly, only CD8 ␣ / ␤ cells were able to recognize a weak agonist peptide derivative variant. This recognition was abolished by Fab Ј fragments of the anti-K d ␣ 3 monoclonal antibody SF1-1.1.1 or substitution of K d D-227 with K, both conditions known to impair CD8 coreceptor function. T cell receptor (TCR) photoaffinity labeling indicated that TCR-ligand binding on CD8 ␣ / ␤ cells was ‫ف‬ 5-and 20-fold more avid than on CD8 ␣ /a and CD8 Ϫ / Ϫ cells, respectively. SF1-1.1.1 Fab Ј or K d mutation D227K reduced the TCR photoaffinity labeling on CD8 ␣ / ␤ cells to approximately the same low levels observed on CD8 Ϫ / Ϫ cells. These results indicate that CD8 ␣ / ␤ is a more efficient coreceptor than CD8 ␣ / ␣ , because it more avidly strengthens TCR-ligand binding.
M
HC class I-restricted TCR ␣ / ␤ ϩ T cells express heterodimeric CD8 consisting of a disulfide linked ␣ and ␤ chain, whereas other cell types, such as NK cells or extrathymic intraepithelial T cells, express homodimeric CD8 ␣ (1, 2). Whereas CD8 ␣ can be surface expressed as CD8 ␣ / ␣ homodimers, CD8 ␤ is expressed only as CD8 ␣ / ␤ heterodimers (3). X-ray crystallography showed that CD8 ␣ is folded in an Ig-like manner (2, 4) . For CD8 ␣ / ␣ , a major CD8 binding site on MHC class I molecules is the acidic loop 222-229, located in the center of the ␣ 3 domain (5, 6) . Moreover, the cytoplasmic tail of CD8 ␣ has been shown to associate with the T cell-specific tyrosine kinase p56 lck (7, 8) and becomes phosphorylated on serine residues upon cell activation (8, 9) .
Less is known about CD8 ␤ . It has only ‫ف‬ 30% sequence homology with CD8 ␣ , and its hinge region is 13 amino acids shorter than the one of CD8 ␣ (1, 2). CD8 ␤ broadens the range of antigen recognition, e.g., CD8 ␣ / ␤ expressing T cell hybridomas were able to recognize ligand variants, but CD8 ␣ / ␣ expressing ones did not (10, 11) . CD8 ␤ also plays a decisive role in thymic differentiation and maturation, since CD8 ␤ "knock out" mice have dramatically reduced numbers of mature CD8 ϩ cells (12, 13) . Transgenic mice expressing "tailless" CD8 ␤ also exhibited a reduced number of mature CD8 ϩ cells, indicating that the cytoplasmatic portion of CD8 ␤ has a functional significance (14) . The recent finding that CD8 ␤ considerably increases CD8-p56 lck association suggests that the tail of CD8 ␤ directly or indirectly interacts with this enzyme (15) .
We have previously developed a system that allows assessment of TCR-ligand interactions by TCR photoaffinity labeling (16, 17) . To this end, the Plasmodium berghei cirumsporozoite peptide PbCS 262-260 (SYIPSAEKI) was modified by replacing PbCS S-252 with photoreactive iodo-4-azidosalicylic acid ( IASA ) and conjugating K-259 with 4-azidobenzoic acid ( ABA ). From mice immunized with this derivative, K d -restricted CTL clones were derived that recognized this conjugate as well as the one lacking the IASA group, but not the derivative lacking the ABA group (17, 18) . Selective photoactivation of IASA permitted crosslinking of the peptide derivative to K d molecules (16) . Incubation of soluble, monomeric K d -peptide derivative complexes with cloned CTL and photoactivation of the ABA group resulted in TCR photoaffinity labeling, which was proportional to TCR-ligand binding (16) (17) (18) . This labeling was not dependent on integrins but dependent on CD8 participation in TCR-ligand binding.
We have previously prepared a T cell hybridoma by fusing cloned T1 CTL with a TCR Ϫ variant of the BW thymoma (19) . This hybridoma expressed T1 TCR but no CD8 ␤ Increase TCR-ligand Binding CD8, because of a fusion mediated silencing of the CD8 ␣ promoter and the inability of CD8 ␤ to be surface expressed in the absence of CD8 ␣ (3, 20) . As assessed by TCR photoaffinity labeling, TCR-ligand binding on this hybridoma was Ͼ 95% weaker than on T1 CTL (19) . CD8 ␣ transfection of the hybridoma resulted in high level expression of CD8 ␣ / ␣ and weak CD8 ␣ / ␤ expression (CD8 ␤ being contributed by the endogenous gene). This transfection only partially restored TCR-ligand binding, suggesting that CD8 ␣/␤ (19) may strengthen TCR-ligand binding more efficienty than CD8␣/␣.
In this study we tested N9 CTL-derived hybridomas that expressed either no CD8 (CD8 Ϫ/Ϫ ), only CD8␣ (CD8␣/␣), or CD8␣/␤ for antigen recognition (IL-2 release) and TCRligand binding (TCR photoaffinity labeling). The results indicate that CD8␣/␤ cells more efficiently recognized antigen, especially a weak antagonist variant, because CD8␣/␤ avidly strengthened TCR-ligand binding.
Materials and Methods
Peptide Derivatives and Photoaffinity Labeling Procedures. All synthetic and analytic procedures were performed essentially as described (16) (17) (18) 21) . In brief, IASA-YIPSAEK(ABA)I and IASA-YIPSAEK(BA)I were obtained by chloramine T-mediated iodination of ASA-Y(PO 3 H 2 )IPSAEK(ABA)I and ASA-Y(PO 3 H 2 ) IPSAEK(BA)I, respectively. Before deprotection and cleavage from the resin, the peptides were NH 2 -terminally acylated with 4-azidosalicyloy-N-hyrdroxysuccinimidyl ester. After iodination with 125 I ‫000,2ف(‬ Ci/mMol) or nonradioactive iodine, the peptides were dephosphorylated with alkaline phosphatase and purified by reverse phase HPLC on a C-18 column. K d and TCR photoaffinity labeling experiments were performed as described (16, 17, 19) . In brief, purified soluble K d was incubated with freshly radiolabeled peptide derivatives at ambient temperature for 2 h, followed by UV irradiation at у350 nm and FPLC gel filtration. For TCR photoaffinity labeling, 8 ϫ 10 6 cells/ml were resuspended in DMEM supplemented with 2% FCS and 20 mM Hepes and incubated in 1 ml aliquots with 1.2 ϫ 10 7 cpm of K dpeptide derivative complex for 1 h at 26ЊC. After UV irradiation at 312 Ϯ 40 nm, the cells were washed and lysed on ice in PBS supplemented with NP-40, Hepes, and protease inhibitors. Immunoprecipitation was performed with anti-TCR mAb H57-297, and the immunoprecipitates were analyzed by SDS-PAGE (10% linear, reducing conditions). The dried gels were evaluated by autoradiography and densitometry. TCR photoaffinity labeling experiments were performed in triplicate and repeated at least twice.
Cell Lines. The T cell hybridoma N9.1 (CD8 Ϫ/Ϫ ) was obtained by fusing cloned N9 CTL (18) with the BW5147 TCR␣␤ Ϫ (BW Ϫ ) thymoma as described (19) . N9.1 cells were transfected with CD8␣ cDNA inserted in the pH pH␤APr-1-neo expression vector (8) and selected in the presence of G418 (2.5 mg/ml). Various stable CD8␣ transfectants were tested by flow cytometry for expression of CD8␤, and one clone was found that was CD8␤ Ϫ . This clone was transfected with a CD8␤ BamHI genomic fragment DNA inserted in the pSV2-his expression vector (pCA257.10). A representative clone (WB1.2) was selected in the presence of histidinol (3 mM). All transfections were performed using protoplast fusion (22) . Murine fibroblast L cells were transfected with K d or K d D227K cDNA as described (23) . IL-2 Release Assay. L-K d or L-K d D227K cells (5 ϫ 10 6 cells/ ml) were incubated in DMEM supplemented with 0.7% FCS and 10 mM Hepes in 10 ml polypropylene tubes (Falcon Plastics, Oxnard, CA) with graded concentrations (10 Ϫ7 -10 Ϫ14 M, in 10-fold dilutions) of peptide derivative at 26ЊC for 2 h. After UV irradiation at у350 nm (16), cells were washed three times, resuspended in DMEM supplemented with 5% FCS and 10 mM Hepes at 10 6 cells/ml, and plated in 100-l aliquots into flat bottom 96-well microtiter plates (Falcon Plastics). The T cell hydridomas, resuspended in the same medium and at the same cell density, were added in 100-l aliquots. Alternatively, hydridomas were incubated either with anti-CD3 mAb (145.2C11, absorbed on plates) or PMA (2.5 ng/ml) and ionomycin (0.5 g/ml). After 24 h of incubation at 37ЊC, supernatants (100 l) were transferred into fresh microtiter plates and incubated for 36-48 h with CTLL indicator cells (4 ϫ 10 3 cells/100 l/well). 1 Ci of [ 3 H]thymidine (Amersham Corp., Arlington Heights, IL), was added per well, and after incubation for an additional 12 h, the cells were harvested and the incorporated [ 3 H]thymidine was measured by ␤ counting (Inotech Harvester and Trace 96 ␤ counter). Each experiment was performed in triplicate and was repeated at least twice.
Results and Discussion
To assess the antigen recognition of the hybridomas under study, they were incubated with L cells expressing covalent K d -IASA-YIPSAEK(ABA)I complexes and the released IL-2 was measured. The L-K d cells were sensitized by incubation with the indicated concentrations of IASA-YIPSAEK(ABA)I and IASA-YIPSAEK(BA)I, respectively, followed by UV irradiation at у350 nm, which produced covalent cell-associated K d -peptide derivative complexes. As shown for a representative experiment in Fig. 1 , all three hybridomas produced IL-2 upon incubation with L cells expressing K d -IASA-YIPSAEK(ABA)I, but CD8␣/␤ cells more efficiently, especially at low degrees of sensitization. Because all three hybridomas expressed comparable levels of TCR and LFA1 (Table 1) and responded similarly upon stimulation with anti-CD3 mAb or PMA and ionomycine (Fig. 1, insets) , these results indicate that CD8␣/␤, but less CD8␣/␣, increased the efficiency of antigen recognition.
More strikingly, the peptide derivative variant IASA-YIPSAEK(BA)I, which lacks the azido function of the ABA group, was efficiently recognized only by CD8␣/␤ cells (Fig. 1) . Half-maximal IL-2 release was observed at Ͼ10-fold higher degree of sensitization than the wild-type conjugate. Substitution of the ABA group with BA reduced the efficiency of recognition by N9 CTL by ‫-05ف‬fold (18) . As assessed by TCR photoaffinity labeling (see below), K d complexes with IASA-YIPSAEK(BA)I bound to the N9 TCR approximately seven times less efficiently than those containing IASA-YIPSAEK(ABA)I (see Fig. 3 D) . The observation that this weak agonist was significantly recognized only by CD8␣/␤ cells is in accordance with reports indicating that CD8␤ broadens the range of antigen recognition by CD8 ϩ T cells (10, 11) and in addition provides a quantitative correlation between antigen recognition and TCR-ligand binding.
To find out why CD8␣/␤ cells efficiently recognize IASA-YIPSAEK(BA)I, we performed the previous experiment (Fig. 1 C) in the presence of FabЈ fragments of the anti-K d ␣3 mAb SF1-1.1.1. This reagent has been shown to impair participation of CD8 in TCR-ligand binding while leaving CD8 mediated adhesion unaffected (19) . As shown in Fig. 2 A, this reagent abolished the efficient recognition of IASA-YIPSAEK(BA)I. Similarly, CD8␣/␤ cells failed to recognize significantly this conjugate on L cells expressing mutant K d D227K, though they well recognized the wild type conjugate (Fig. 2 B) . This K d mutation has been shown to dramatically impair CD8-MHC class I interactions (5, 6, 19) . The finding that CD8␣/␤ cells under conditions that prevent CD8 participation in TCR-ligand binding failed, as CD8␣/␣ cells, to significantly recognize the weak agonist IASA-YIPSAEK(BA)I suggests that CD8␣/␤ more avidly strengthens TCR-ligand binding than CD8␣/␣. The utilized system allowed to test this possibility, because it permits direct assessment of CD8 participation in TCR-ligand binding by TCR photoaffinity labeling with soluble covalent K d -peptide derivative complexes (16, 17, 19) . TCR photoaffinity labeling with K d -125 IASA-YIPSAEK (ABA)I on CD8␣/␤ cells was ‫5ف‬ and 20 times more efficient than on CD8␣/␣ cells and CD8 Ϫ/Ϫ cells, respectively (Fig. 3, A and B) . The background, e.g., nonspecific labeling, was 1-2%, as observed in the presence of the ␣-K d ␣1 mAb 20-8-4S, which blocks specific TCR-ligand binding (16, 19) . Because CD8␣/␣ cells expressed more CD8␣ than N9 CTL or CD8␣/␤ cells expressed CD8␣/␤ (Table 1 ), these results demonstrate that heterodimeric CD8␣/␤ indeed more avidly strengthens TCR-ligand binding than homodimeric CD8␣/␣. This is in accordance with preceeding experiments, in which various CD8␣ and CD8␣ plus CD8␤ transfectants of CD8 Ϫ/Ϫ N9.1 cells or subclones of CD8␣/␤ WB1.2 were likewise tested (unpublished results). ( Figs. 2 and 3) . We thus conclude that CD8␣/␤ cells more efficiently recognize antigen than CD8␣/␣ cells, because CD8␣/␤ more avidly strengthens TCR-ligand binding. Although our results do not rule out that other factors may play a role as well (i.e., that CD8␣/␤ has superior signaling capabilities or more efficiently mediates CD8-dependent adhesion), they clearly demonstrate that CD8␤ significantly increases CD8 participation in TCR-ligand binding, and this predictably is important for antigen recognition, especially of weak agonists.
It remains to be explained why CD8␣/␤ more efficiently increases TCR-ligand binding than CD8␣/␣. It is conceivable that either CD8␣/␤ more avidly binds MHC class I molecules or that it more efficiently "couples" with TCR/CD3, thus defining an orientation of CD8 relative to the TCR that favors coordinate ligand binding. Although CD8␣/␣ and CD8␣/␤ both have been shown to bind MHC class I molecules (5, 24) , it is unknown whether they do so with different affinities. In support of the second possibility, we have previously observed that the dynamics of TCR-ligand interactions on CTL clones are modulated by CD8 in a time-and temperature-dependent manner (16, 19) . Moreover, several reports indicate that CD8 interacts with TCR/CD3 complex (25, 26) , which in view of our present data may imply that CD8␤ plays an important role in such interactions. Interestingly, CD8␤ has been shown to significantly increase the association of CD8 with the tyrosine kinase p56 lck (15) . In the CD4 system, p56 lck is known to be involved in coupling CD4 with TCR/CD3 (27) . If the same were true for CD8, it would explain why CD8␣/␤ is a more efficient coreceptor than CD8␣/␣. The system described here, by including kinetic experiments and further genetic engineering of the hybridomas, should now permit detailed analysis of the role of CD8␤ in T cell function.
The efficient TCR photoaffinity labeling on CD8␣/␤ cells was reduced in the presence of SF1-1.1.1 FabЈ to the same low levels as observed on CD8 Ϫ/Ϫ cells (Fig. 3, A and B) . The TCR photoaffinity labeling on CD8␣/␣ was also reduced in the presence of this reagent, but for unknown reasons to a slightly lesser degree than on CD8␣/␤ cells. The lack of a significant inhibition of the TCR photoaffinity labeling on CD8 Ϫ/Ϫ cells in the presence of SF1-1.1.1 FabЈ showed that this reagent does not affect the TCRligand interaction per se, but rather the CD8 participation in TCR-ligand binding. Similarly, when TCR photoaffinity labeling on CD8␣/␤ cells was performed with soluble K d D227K-IASA-YIPSAEK(ABA)I, nearly five times weaker labeling was observed than with the wild type ligand (Fig. 3  C) . In contrast, on CD8 Ϫ/Ϫ cells, both ligands exhibited essentially the same weak TCR photoaffinity labeling, confirming our previous finding that this K d mutation does not significantly affect the actual TCR-ligand binding, but rather its dependence on CD8 (Fig. 3 B and reference 19) .
The peptide derivative variant IASA-YIPSAEK(BA)I, lacking an orthogonal photoreactive group, can cross-link to K d , but not to TCR; therefore, the binding of K d -IASA-YIPSAEK(BA)I to N9 TCR was assessed by its ability to inhibit the TCR photoaffinity labeling by K d -IASA-YIP-SAEK(ABA)I. As shown in Fig. 3 D, This work was supported by grants from the Institut National de la Santé et de la Recherche Médicale/Centre National de la Recherche Scientifique, Ligue Nationale Contre le Cancer and Association pour le Recherche sur le Cancer.
